ERBB2 and inflammatory breast carcinoma: The hormone receptor-positive subtype (estrogen and progesterone) is relatively rare in IBC (30%) compared to non-IBC (60–80%), and the subtypes HER-2 (erb-b2 receptor tyrosine kinase 2)-enriched and triple-negative are more frequent in IBC [36,37].